These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1083962)

  • 1. The effect of apomorphine and ergocriptine on the release of MSH by the pars intermedia of Rana pipiens.
    Smith AF
    Neuroendocrinology; 1975; 19(4):363-76. PubMed ID: 1083962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory activity of the intraocular homotransplanted pars intermedia of the frog, Rana nigromaculata.
    Ito T; Yeh WH; Nishiyama K
    Neuroendocrinology; 1986; 43(6):689-95. PubMed ID: 3762865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2-like dopamine receptor mediates dopaminergic or gamma-aminobutyric acidergic inhibition of melanotropin-releasing hormone release from the pars intermedia in frogs (Rana nigromaculata).
    Tonosaki Y; Nishiyama K; Honda T; Ozaki N; Sugiura Y
    Endocrinology; 1995 Dec; 136(12):5260-5. PubMed ID: 7588269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of receptors for dopamine in the pars intermedia of the amphibian Xenopus laevis.
    Verburg-Van Kemenade BM; Tonon MC; Jenks BG; Vaudry H
    Neuroendocrinology; 1986; 44(4):446-56. PubMed ID: 3822075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone prevents dark-background adaptation in amphibians.
    Mennin SP; Saland LC
    Neuroendocrinology; 1980 Dec; 31(6):385-9. PubMed ID: 6969864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innervation of the pars intermedia and control of alpha-melanotropin secretion in the newt.
    Danger JM; Perroteau I; Franzoni MF; Saint-Pierre S; Fasolo A; Vaudry H
    Neuroendocrinology; 1989 Nov; 50(5):543-9. PubMed ID: 2514395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone induces melanocyte-stimulating hormone release and degenerative changes in pituitary innervation in amphibians.
    Saland LC; Comunas F; Maez D
    Neuropeptides; 1986; 8(2):133-41. PubMed ID: 3489902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of single melanophores to extracellular and intracellular iontophoretic injection of melanocyte-stimulating hormone.
    Horowitz JM; Mikuckis GM; Longshore MA
    Endocrinology; 1980 Mar; 106(3):770-7. PubMed ID: 6965477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ergocornine on melanophores of Ambystoma tigrinum: evidence for suppression of pituitary MSH release.
    Platt JE; Norris DO
    J Exp Zool; 1974 Jul; 189(1):7-12. PubMed ID: 4366221
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholaminergic control of alpha-melanocyte-stimulating hormone (alpha MSH) release by frog neurointermediate lobe in vitro: evidence for direct stimulation of alpha MSH release by thyrotropin-releasing hormone.
    Tonon MC; Leroux P; Stoeckel ME; Jegou S; Pelletier G; Vaudry H
    Endocrinology; 1983 Jan; 112(1):133-41. PubMed ID: 6401174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic regulation of melanocyte-stimulating hormone secretion from the pars intermedia of Xenopus laevis: immunocytochemical and physiological evidence.
    Verburg-van Kemenade BM; Tappaz M; Paut L; Jenks BG
    Endocrinology; 1986 Jan; 118(1):260-7. PubMed ID: 3000738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence against mass action direct feedback control of melanophore-stimulating hormone (MSH) release.
    Huntington T; Hadley ME
    Endocrinology; 1974 Aug; 95(2):472-9. PubMed ID: 4546804
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin.
    Hadley ME; Anderson B; Heward CB; Sawyer TK; Hruby VJ
    Science; 1981 Aug; 213(4511):1025-7. PubMed ID: 6973820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of structure-activity relationships within alpha-MSH on melanophores of Anolis carolinensis and Rana pipiens.
    Lucas A; Shuster S; Thody AJ; Eberle AN; Girard J
    Regul Pept; 1987 Jul; 18(1):43-50. PubMed ID: 3498189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1975; 17(4):296-308. PubMed ID: 1079927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanophore stimulating hormone (MSH) release: inhibition by cytochalasin B and "stimulation" by dimethyl sulfoxide.
    Bower SA; Hadley ME
    Endocrinology; 1975 Feb; 96(2):431-9. PubMed ID: 1078655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergot alkaloid inhibition of melanophore stimulating hormone secretion.
    Morgan CM; Hadley ME
    Neuroendocrinology; 1976; 21(1):10-9. PubMed ID: 1004685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1978; 25(5):275-90. PubMed ID: 206853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone does not alter the release of melanocyte-stimulating hormone or adrenocorticotropic hormone from the rat pars intermedia.
    Kraicer J
    Neuroendocrinology; 1977; 24(3-4):226-31. PubMed ID: 204881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.